From the Association for Clinical and Translational Science (ACTS):

Through a bipartisan budget deal enacted at the end of last year, Congress provided appropriators with an FY 2014 federal spending level of $1.012 trillion for discretionary programs. The FY 2014 allocation, advanced through the omnibus package, is a significant increase over the FY 2013 sequester-mandated spending cap of $987 billion. In addition to providing new funding, the FY 2014 omnibus appropriations package also cancels the FY 2014 sequester cut of 2.1 percent, originally scheduled to take place later this month.

Of particular interest to ACTS members, the FY 2014 omnibus appropriations package includes the following items:

$633.27 million for the National Center for Advancing Translational Sciences (NCATS), an increase of $90 million over the FY 2013 post-sequestration level.
$474.74 million for the Clinical and Translational Science Awards Program at NCATS, an increase of approximately $39 million over the FY 2013 post-sequestration level.
CSTA Program – The agreement provides a specific funding level for the core CTSA program within the NCATS statutory language. This change removes the funding flexibility provided during the establishment years of NCATS.
$2.36 billion for the National Institute of General Medical Sciences (NIGMS), an increase of $136 million over the FY 2013 post-sequestration level.
$273.33 million for the Institutional Development Award (IDeA) program at NIGMS, an increase of $12 million over the FY 2013 post-sequestration level.
You can read more in the advocacy section of the ACTS website

UAMS is in its fifth and final year of a Clinical and Translational Science Award (CTSA), which is funded through the NIH and the National Center for Advancing Translational Sciences (NCATS). TRI and UAMS research leaders are working on an application for a second CTSA.